Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation

Transplant Infectious Disease

Volumn 10, Issue 3, 2008, Pages 184-189

  Fiel, M I ^a,b   Shukla, D ^b   Saraf, N ^a   Xu, R ^b   Schiano, T D ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Hepatic granulomas; Hepatitis C; Liver transplant; Pegylated interferon; Recurrent HCV; Ribavirin

Indexed keywords

ALPHA2B INTERFERON; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON; RIBAVIRIN; TACROLIMUS; VIRUS RNA;

ADULT; AGED; ALLOGRAFT; ARTICLE; DATA BASE; FEMALE; GRAFT REJECTION; HEPATITIS C; HEPATITIS C VIRUS; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER GRANULOMA; LIVER TRANSPLANTATION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; VIRUS LOAD;

ADULT; AGED; ANTIVIRAL AGENTS; BIOPSY; FEMALE; GRANULOMA; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; LIVER; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RIBAVIRIN; SARCOIDOSIS;

EID: 43949120772     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2007.00258.x     Document Type: Article

References (38)

1. Rubin RH. Infection in the organ transplant recipient. In : Rubin RH, Young LS, eds. Clinical Approach to Infection in the Compromised Host. New York : Kluwer Academic/Plenum Publishers, 2002 : 573 679.
2. Hubscher SG, Elias E, Buckels JA, Mayer AD, McMaster P, Neuberger JM. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J Hepatol 1993 18 : 173 184.
3. Hashimoto E, Shimada M, Noguchi S, et al. Disease recurrence after living liver transplantation for primary biliary cirrhosis: a clinical and histological follow-up study. Liver Transpl 2001 7 : 596 599.
4. Lipson EJ, Fiel MI, Florman SS, Korenblat KM. Patient and graft outcomes following liver transplantation for sarcoidosis. Clin Transplant 2005 19 : 487 491.
5. Cengiz C, Rodriguez-Davalos M, deBoccardo G, et al. Recurrent hepatic sarcoidosis post-liver transplantation manifesting with severe hypercalcemia: a case report and review of the literature. Liver Transpl 2005 11 : 1611 1614.
6. Gaya DR, Thorburn D, Oien KA, Morris AJ, Stanley AJ. Hepatic granulomas: a 10 year single center experience. J Clin Pathol 2003 56 : 850 853.
7. Goldin RD, Levine TS, Foster GR, et al. Granulomas in hepatitis C. Histopathology 1996 28 : 265 267.
8. Emile JF, Sebagh M, Feray C, et al. The presence of epithelioid granulomas in hepatitis C-related cirrhosis. Hum Pathol 1993 24 : 1095 1097.
9. Ozaras R, Tahan V, Mert A, et al. The prevalence of hepatic granulomas in chronic hepatitis C. J Clin Gastroenterol 2004 38 : 449 452.
10. Harada K, Minato H, Hiramatsu K, Nakanuma Y. Epithelioid cell granulomas in chronic hepatitis C: immunohistochemical character and histological marker of favourable response to interferon-α therapy. Histopathology 1998 33 : 216 221.
11. Yamamoto S, Iguchi Y, Ohomoto K, Mitsui Y, Shimabara M, Mikami Y. Epitheloid granuloma formation in type C chronic hepatitis: report of two cases. Hepatogastroenterology 1995 42 : 291 293.
12. Pichardo-Bahena R, Mendez-Sanchez N. Epithelioid granulomas in a patient with hepatitis C virus. Ann Hepatol 2002 1 : 91 93.
13. Mert A, Tabak F, Ozaras R, Tahan V, Senturk H, Ozbay G. Hepatic granulomas in chronic hepatitis C. J Clin Gastroenterol 2001 33 : 342 343.
14. Marzouk K, Saleh S, Kannass M, Sharma OP. Interferon-induced granulomatous lung disease. Curr Opin Pulm Med 2004 10 : 435 440.
15. Bolukbas C, Bolukbas FF, Kebdir T, et al. Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C - a case report and review of the literature. Acta Gastroenterol Belg 2005 68 : 432 434.
16. Butnor KJ. Pulmonary sarcoidosis induced by interferon-alpha therapy. Am J Surg Pathol 2005 29 : 976 979.
17. Hurst EA, Mauro T. Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C. Arch Dermatol 2005 141 : 865 868.
18. Alazemi S, Campos MA. Interferon-induced sarcoidosis. Int J Clin Pract 2006 60 : 201 211.
19. Veerabagu MP, Finkelstein SD, Rabinovitz M. Granulomatous hepatitis in a patient with chronic hepatitis C treated with interferon-alpha. Dig Dis Sci 1997 42 : 1445 1448.
20. Propst A, Propst T, Dietze O, Kathrein H, Judmeier G, Vogel W. Development of granulomatous hepatitis during treatment with interferon-alpha-2b. Dig Dis Sci 1995 40 : 2117 2118.
21. Ryan BM, McDonald GS, Pilkington R, Kelleher D. The development of hepatic granulomas following interferon-alpha2b therapy for chronic hepatitis C infection. Eur J Gastroenterol Hepatol 1998 10 : 349 351.
22. Celik G, Sen E, Ulger AF, et al. Sarcoidosis caused by interferon therapy. Respirology 2005 10 : 535 540.
23. Lefkowitch JH. Hepatic granulomas. J Hepatol 1999 30 (Suppl 1) : 40 45.
24. Denk H, Scheuer PJ, Baptista A, et al. Guidelines for the diagnosis and interpretation of hepatic granulomas. Histopathology 1994 25 : 209 218.
25. Co DO, Hogan LH, Il-Kim S, Sandor M. T cell contributions to the different phases of granuloma formation. Immunol Lett 2004 92 : 135 142.
26. Yoneyama H, Ichida T. Recruitment of dendritic cells to pathological niches in inflamed liver. Med Mol Morphol 2005 38 : 136 141.
27. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology 1992 15 : 567 571.
28. Batts KP, Wang X. Recurrence of primary biliary cirrhosis, autoimmune cholangitis and primary sclerosing cholangitis after liver transplantation. Clin Liver Dis 1998 42 : 421 435.
29. Biggins SW, Terrault NA. Treatment of recurrent hepatitis C after liver transplantation. Clin Liver Dis 2005 9 : 5030523.
30. Midturi J, Sierra-Hoffman M, Hurley D, Winn R, Beissner R, Carpenter J. Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: case report and review of the literature. Clin Infect Dis 2004 39 : 1724 1729.
31. Leclerc S, Myers RP, Moussalli J, Herson S, Poynard T, Benveniste O. Sarcoidosis and interferon therapy: report of five cases and review of the literature. Eur J Intern Med 2003 14 : 237 243.
32. Hirano A, Kataoka M, Nakata Y, et al. Sarcoidosis occurring after interferon-α therapy for chronic hepatitis C: report of two cases. Respirology 2005 10 : 529 534.
33. Gitlin N. Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases. Eur J Gastroenterol Hepatol 2002 14 : 883 885.
34. Barcena R, Sanroman AL, Del Campo S, et al. Posttransplant liver granulomatosis associated with hepatitis C? Transplantation 1998 65 : 1494 1495.
35. Farges O, Bismuth H, Sebagh M, Reynes M. Granulomatous destruction of bile ducts after liver transplantation: primary biliary cirrhosis recurrence or hepatitis C virus infection? Hepatology 1995 21 : 1765 1767.
36. Hunt J, Gordon FD, Jenkins RL, Lewis WD, Khettry U. Sarcoidosis with selective involvement of a second liver allograft: report of a case and review of the literature. Mod Pathol 1999 12 : 325 328.
37. Kontorinis N, Agarwal K, Elhajj N, Fiel MI, Schiano TD. Pegylated interferon immune-mediated hepatitis post-liver transplantation. Liver Transpl 2006 12 : 827 830.
38. Gerardi S, Lodato F, Gramenzi A, et al. "De novo" autoimmune disorders in liver transplanted patients treated with pegylated interferon-alfa-2b and ribavirin for hepatitis C recurrence. Hepatology 2005 42 : 483A.